Moderna Spikes 20%, Dow Futs Soar On Promising Early COVID Vaccine Trial Data
“The researchers found that at two lower dose levels used in the study, levels of antibodies found after getting a second booster shot of the vaccine either equaled or exceeded the levels of antibodies found in patients who had recovered from the virus.”
https://www.zerohedge.com/markets/moderna-shares-spike-20-promising-early-trial-data